|
FOR US RESIDENTS ONLY
|
Open a World of Support for Ph+ CML
CML Therapy Support For Patients and Caregivers
Novartis, the global leader in Ph+ CML therapy, has been working with healthcare professionals and patients worldwide for more than 5 years to improve the treatment of Ph+ CML.
Novartis introduces CML Alliance™, a unique support program designed to help optimize outcomes in Ph+ CML patients.
• Programs designed to help improve adherence to Ph+ CML therapy
• Access to reimbursement support
• Valuable educational information on living with Ph+ CML, including www.LivingWithCML.com
Use of this website is governed by the
Terms of Use
and
Privacy Statement
.
Copyright 2008 Novartis Pharmaceuticals Corporation. All Rights Reserved.
|